New drug for diabetic kidney disease to reduce protein in urine
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests an investigational drug called LC-Z300-01 to see if it can reduce protein in the urine of people with diabetic kidney disease. It aims to protect kidney function and slow down kidney damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 2 diabetes and a doctor-confirmed kidney problem caused by diabetes (this shows up as protein in your urine).
- Your average blood sugar (HbA1c) is 9% or lower.
- You have protein in your urine (either a urine test showing at least 30 mg/g or 300 mg in a 24-hour collection).
- Your kidney function is relatively good (eGFR of 60 or higher).
- You are already taking a standard blood pressure medication for your kidneys (or you cannot take it due to side effects).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new drug, R3R01, can help reduce protein leaking into the urine in people with diabetic kidney disease. It may offer a new option for managing kidney health.
This study tests a new medicine called AP303 for people with type 2 diabetes and chronic kidney disease. The goal is to see if it is safe and how the body processes it. If you have diabetes and your kidneys are not working as well as they used to, this trial might help find new treatment options.
This Phase 2 study tests whether adding NAD can improve kidney health in people with diabetes-related kidney disease. It is designed for people with certain urine lab results showing kidney stress, while keeping blood sugar and safety limits within range.
This trial tests if dapagliflozin, a medication that lowers blood sugar and protects the kidneys, can reduce protein in the urine of children with inherited kidney disease. It may help preserve kidney function when added to standard blood pressure medication.
This study tests a new medicine called YG1699 to see how it works in people who have both diabetes and kidney disease, including those on dialysis. It may help control blood sugar, but we need to learn more about its effects.
This study tests an investigational drug called ALN-ANG3 to see if it can help people with diabetic kidney disease. The drug may reduce kidney damage and slow down the loss of kidney function. If you join, you will get the study drug or a placebo (a dummy shot) and be followed by a study doctor.
Hear when a new Diabetic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.